Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117249) titled 'Efficacy and safety of Dorzagliatin in real-world populations with type 2 diabetes: a China multicenter retrospective study (EASTERN Study)' on Jan. 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
diabetes
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-01
Target Sample Size: Dorzagliatin group:800;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307018
Disclaimer: Curated by HT Syndication....